gemcabene has been researched along with Neuralgia, Postherpetic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amantea, M; Benincosa, LJ; Corrigan, BW; Ewy, W; Glue, P; Hutmacher, MM; Koide, H; Kowalski, KG; Lalonde, RL; Lockwood, PA; Marshall, SA; Miller, R; Milligan, PA; Nichols, DJ; Parivar, K; Tensfeldt, TG | 1 |
1 review(s) available for gemcabene and Neuralgia, Postherpetic
Article | Year |
---|---|
Model-based drug development.
Topics: Alzheimer Disease; Amines; Analgesics; Animals; Anticholesteremic Agents; Bridged Bicyclo Compounds, Heterocyclic; Caproates; Cholesterol; Clinical Trials as Topic; Cognition; Computer Simulation; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Approval; Drug Design; Gabapentin; gamma-Aminobutyric Acid; Glycoproteins; Guidelines as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunologic Factors; Meta-Analysis as Topic; Models, Biological; Models, Statistical; Muscarinic Agonists; Neuralgia, Postherpetic; Neutrophil Infiltration; Oximes; Pharmacokinetics; Pharmacology; Reproducibility of Results; Research Design; Stroke; United States; United States Food and Drug Administration | 2007 |